Leslie Tari, CHIEF SCIENTIFIC OFFICER at Cidara Therapeutics, Inc. (CDTX), bought 10,000 shares at $0.97 ($10K) on 2023-08-14, disclosed to the SEC on 2023-08-14.
Open-market purchase of $10k CDTX by CHIEF SCIENTIFIC OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CDTX | SELL | 2024-03-12 | $14K | — | Filing → |
| CDTX | SELL | 2023-09-13 | $18K | — | Filing → |
| CDTX | SELL | 2023-03-13 | $12K | — | Filing → |